消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理

2020-11-26 韩国胃肠内镜学会 Clin Endosc . 2020 Nov 26.

胃肠内镜

2020年11月，韩国胃肠内镜学会(KSGE)发布了胃肠内镜检查中抗栓药物的管理指南。抗栓药物包括抗血小板药物和抗凝药物，对于应用抗栓药物的患者进行胃肠内镜检查的管理在临床上充满挑战。本文主要针对这类

中文标题：

2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理

英文标题：

Clinical Practice Guideline for the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy

发布机构：

韩国胃肠内镜学会

发布日期：

2020-11-26

简要介绍：

2020年11月，韩国胃肠内镜学会(KSGE)发布了胃肠内镜检查中抗栓药物的管理指南。抗栓药物包括抗血小板药物和抗凝药物，对于应用抗栓药物的患者进行胃肠内镜检查的管理在临床上充满挑战。本文主要针对这类患者的管理提供指导建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a3e731c00201869f, title=2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理, enTitle=Clinical Practice Guideline for the Management of Antithrombotic Agents in Patients Undergoing Gastrointestinal Endoscopy, guiderFrom=Clin Endosc . 2020 Nov 26., authorId=0, author=, summary=2020年11月，韩国胃肠内镜学会(KSGE)发布了胃肠内镜检查中抗栓药物的管理指南。抗栓药物包括抗血小板药物和抗凝药物，对于应用抗栓药物的患者进行胃肠内镜检查的管理在临床上充满挑战。本文主要针对这类, cover=https://img.medsci.cn/2020121/1606753417466_2020535.jpg, journalId=0, articlesId=null, associationId=1404, associationName=韩国胃肠内镜学会, associationIntro=, copyright=0, guiderPublishedTime=Thu Nov 26 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月，韩国胃肠内镜学会(KSGE)发布了胃肠内镜检查中抗栓药物的管理指南。抗栓药物包括抗血小板药物和抗凝药物，对于应用抗栓药物的患者进行胃肠内镜检查的管理在临床上充满挑战。本文主要针对这类患者的管理提供指导建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=17990, tagName=胃肠内镜)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=17990, guiderKeyword=胃肠内镜, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4151, appHits=109, showAppHits=0, pcHits=446, showPcHits=4042, likes=2, shares=12, comments=9, approvalStatus=1, publishedTime=Mon Nov 30 00:34:04 CST 2020, publishedTimeString=2020-11-26, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=qiushida2, createdTime=Mon Nov 30 23:45:55 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 08:59:36 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理.pdf)])
2020 KSGE临床实践指南：胃肠内镜检查中抗栓药物的管理.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1191123, encodeId=8111119112333, content=知识面广，有参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:12:47 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055338, encodeId=bfaf10553387c, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Mon Sep 27 13:55:54 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909184, encodeId=8f7b90918413, content=好管理！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 18 17:55:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908894, encodeId=60e69088945e, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 17 18:01:46 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908154, encodeId=d5d6908154aa, content=大有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:24:04 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2022-02-08 ms3000000637975859

    知识面广，有参考价值

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1191123, encodeId=8111119112333, content=知识面广，有参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:12:47 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055338, encodeId=bfaf10553387c, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Mon Sep 27 13:55:54 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909184, encodeId=8f7b90918413, content=好管理！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 18 17:55:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908894, encodeId=60e69088945e, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 17 18:01:46 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908154, encodeId=d5d6908154aa, content=大有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:24:04 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2021-09-27 ms2000000182667314

    很有用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1191123, encodeId=8111119112333, content=知识面广，有参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:12:47 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055338, encodeId=bfaf10553387c, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Mon Sep 27 13:55:54 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909184, encodeId=8f7b90918413, content=好管理！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 18 17:55:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908894, encodeId=60e69088945e, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 17 18:01:46 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908154, encodeId=d5d6908154aa, content=大有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:24:04 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-18 jyzxjiangqin

    好管理！

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1191123, encodeId=8111119112333, content=知识面广，有参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:12:47 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055338, encodeId=bfaf10553387c, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Mon Sep 27 13:55:54 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909184, encodeId=8f7b90918413, content=好管理！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 18 17:55:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908894, encodeId=60e69088945e, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 17 18:01:46 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908154, encodeId=d5d6908154aa, content=大有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:24:04 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-17 jyzxjiangqin

    好指南！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1191123, encodeId=8111119112333, content=知识面广，有参考价值, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Tue Feb 08 19:12:47 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055338, encodeId=bfaf10553387c, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0a85549889, createdName=ms2000000182667314, createdTime=Mon Sep 27 13:55:54 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=909184, encodeId=8f7b90918413, content=好管理！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Fri Dec 18 17:55:14 CST 2020, time=2020-12-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908894, encodeId=60e69088945e, content=好指南！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Thu Dec 17 18:01:46 CST 2020, time=2020-12-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908154, encodeId=d5d6908154aa, content=大有收获, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf645444609, createdName=紫依, createdTime=Tue Dec 15 11:24:04 CST 2020, time=2020-12-15, status=1, ipAttribution=)]
    2020-12-15 紫依

    大有收获

    0

相关指南

2016 ESGE/ESPGHAN指南：儿童胃肠内镜检查

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2016-09-12

拓展阅读

2016 ESGE/ESPGHAN指南：儿童胃肠内镜检查

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2016-09-12

COVID-19大流行期间的胃肠内镜临床和操作指导 2020

暂未更新 · 2020-10-22

2021 ESGE/ESGENA立场声明：胃肠内镜手术安全检查表实施指导

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2021-12-14